BSEBoard Meeting4 Aug 2026 · 4 Aug 2026, 04:45 pm
Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Standalone and Consolidated ....
Alpa Laboratories Ltd · 532878
✦ AI SummaryResults
Alpa Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve the standalone and consolidated unaudited financial results for the quarter ended on 30th June, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alpa Laboratories Ltd - 532878 - Board Meeting Intimation for Approval Of The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30Th June, 2026
Attachments (1)
📄pdf
Download →
85bd1f11-4da5-4189-853f-f5db3603afc6.pdf
View document text
Alpa Laboratories Ltd.
33/2, Pigdamber A.B. Road - 453 446 Distt. Indore - (M.P.) India
Phone No. : +91 731-429 4567 Fax No. : +91 730-429 4444
Email : mktgdom@alpalabs.in
CIN : L85195MP1988PLC004446
Date: - 04" August, 2026
Listing Department, Listing Department,
National Stock Exchange of India Limited. Bombay Stock Exchange Limited.
‘Exchange Plaza’, C-1, Block G, Rotunda Building, P J Towers,
Bandra - Kurla Complex, Dalal Street, Fort,
Bandra (E), Mumbai - 400 051 Mumbai - 400 001
Scrip Code: ALPA Scrip Code: 532878
Subject: Intimation of Board Meeting under Regulation 29 and Regulation 30 of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam,
This is to Inform you that in terms of Regulations 29(1)(a) and Regulation 30 oft he Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the
meeting of the Board of Directors of the Company is scheduled to be held on
Thursday, 13" day of August, 2026 at 03:00 P.M. at the Registered Office of the Company, inter alia,
to consider:
1. The Standalone and Consolidated unaudited Financial Results for the Quarter ended on 30™
June, 2026.
2. To approve the notice of 38" Annual General Meeting of the Company.
Any other matters as may be decided by the board ofd irectors
This is for the information of the exchange and members thereof.
Thanking you,
Yours faithfully,
FOR ALPA LABORATORIES LIMITED
Wohon A
Mahendra Singh Chawla
Director
DIN: 00362058